ArticlePeerJ2023

A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma.

Zewei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.